MERTK and neoplasm: The tumors demonstrated slower tumor progression and decreased metastasis [60], suggesting that the presence MERTK in the tumor-infiltrating cells, presumably the myeloid population, somehow suppressed an immune response; conversely, absence of MERTK triggered a level of immune tumor rejection, since there was no treatment administered in these experiments.